🇺🇸 Bimatoprost Ophthalmic Solution in United States

37 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Eye Irritation — 7 reports (18.92%)
  2. Ocular Hyperaemia — 7 reports (18.92%)
  3. Drug Ineffective — 5 reports (13.51%)
  4. Eye Pain — 4 reports (10.81%)
  5. Product Quality Issue — 3 reports (8.11%)
  6. Wrong Technique In Product Usage Process — 3 reports (8.11%)
  7. Drug Ineffective For Unapproved Indication — 2 reports (5.41%)
  8. No Adverse Event — 2 reports (5.41%)
  9. Off Label Use — 2 reports (5.41%)
  10. Product Substitution Issue — 2 reports (5.41%)

Source database →

Other Ophthalmology approved in United States

Frequently asked questions

Is Bimatoprost Ophthalmic Solution approved in United States?

Bimatoprost Ophthalmic Solution does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Bimatoprost Ophthalmic Solution in United States?

Allergan is the originator. The local marketing authorisation holder may differ — check the official source linked above.